Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Fortner

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
American Journal of Hospital Pharmacy|August 1, 1979
Comparative auditory toxicity of aminoglycoside antibiotics in leukopenic patientsJ F Bender, C L Fortner, S C Schimpff, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1979
Role of vancomycin as a component of oral nonabsorbable antibiotics for microbial suppression in leukemic patientsJ F Bender, S C Schimpff, V M Young, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1980
Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patientsJ C Wade, S C Schimpff, K A Newman, et al.
The American Journal of Medicine|April 1, 1979
Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancerL J Love, S C Schimpff, D M Hahn, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1982
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patientsR S Finley, C L Fortner, C A deJongh, et al.
The American Journal of Medicine|July 1, 1982
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacinC A De Jongh, J C Wade, S C Schimpff, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
American Journal of Hospital Pharmacy|August 1, 1979
Comparative auditory toxicity of aminoglycoside antibiotics in leukopenic patientsJ F Bender, C L Fortner, S C Schimpff, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1979
Role of vancomycin as a component of oral nonabsorbable antibiotics for microbial suppression in leukemic patientsJ F Bender, S C Schimpff, V M Young, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1980
Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patientsJ C Wade, S C Schimpff, K A Newman, et al.
The American Journal of Medicine|April 1, 1979
Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancerL J Love, S C Schimpff, D M Hahn, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1982
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patientsR S Finley, C L Fortner, C A deJongh, et al.
The American Journal of Medicine|July 1, 1982
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacinC A De Jongh, J C Wade, S C Schimpff, et al.
Pageof 4